Cardiovascular GLP-1 indication approval 2026: Both in 2026
44%YES chance
Yes
44%
No
56%
Now 44.1%
Resolution
Resolves to the first GLP-1 to win an additional cardiovascular indication from FDA in 2026.
Source: https://www.fda.gov/
Resolves by Apr 8, 2027.
Recent trades
- NO@darbyblake109 sh@ 44%58 SP
- NO@blakeunderhill10 sh@ 50%5 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.